{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:01:52Z","timestamp":1791900112039,"version":"4.3.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 82394434"],"award-info":[{"award-number":["Grant No. 82394434"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 62333002"],"award-info":[{"award-number":["Grant No. 62333002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00259-025-07485-8","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T03:39:20Z","timestamp":1754537960000},"page":"1169-1182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Glucose metabolism alterations and A\u03b2 deposition in AD and FTD are related to the distribution of neurotransmitter systems"],"prefix":"10.1007","volume":"53","author":[{"given":"Sheng","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixiao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0315-7930","authenticated-orcid":false,"given":"Shaozhen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"7485_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","volume":"16","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Wang X. Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy. Protein Cell. 2025;16:83\u2013120. https:\/\/doi.org\/10.1093\/procel\/pwae026.","journal-title":"Protein Cell"},{"key":"7485_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411732","volume":"24","author":"A Antonioni","year":"2023","unstructured":"Antonioni A, Raho EM, Lopriore P, Pace AP, Latino RR, Assogna M, et al. Frontotemporal dementia, where do we stand?? A narrative review. Int J Mol Sci. 2023;24: 11732. https:\/\/doi.org\/10.3390\/ijms241411732.","journal-title":"Int J Mol Sci"},{"key":"7485_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102375","volume":"99","author":"J Ding","year":"2024","unstructured":"Ding J, Yang Q, Drossinos N, Guo Q. Advances in semantic dementia: neuropsychology, pathology & neuroimaging. Ageing Res Rev. 2024;99: 102375. https:\/\/doi.org\/10.1016\/j.arr.2024.102375.","journal-title":"Ageing Res Rev"},{"issue":"11","key":"7485_CR4","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/s1474-4422(20)30314-8","volume":"19","author":"G Ch\u00e9telat","year":"2020","unstructured":"Ch\u00e9telat G, Arbizu J, Barthel H, Garibotto V, Law I, Morbelli S, et al. Amyloid-PET and (18)F-FDG-PET in the diagnostic investigation of Alzheimer\u2019s disease and other dementias. Lancet Neurol. 2020;19(11):951\u201362. https:\/\/doi.org\/10.1016\/s1474-4422(20)30314-8.","journal-title":"Lancet Neurol"},{"key":"7485_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/s1474-4422(12)70142-4","volume":"11","author":"CM Clark","year":"2012","unstructured":"Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, et al. Cerebral PET with Florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study. Lancet Neurol. 2012;11:669\u201378. https:\/\/doi.org\/10.1016\/s1474-4422(12)70142-4.","journal-title":"Lancet Neurol"},{"key":"7485_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/bios10080101","volume":"10","author":"S Banerjee","year":"2020","unstructured":"Banerjee S, McCracken S, Hossain MF, Slaughter G. Electrochemical detection of neurotransmitters. Biosens (Basel). 2020;10:101. https:\/\/doi.org\/10.3390\/bios10080101.","journal-title":"Biosens (Basel)"},{"key":"7485_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23115954","volume":"23","author":"RI Teleanu","year":"2022","unstructured":"Teleanu RI, Niculescu AG, Roza E, Vlad\u00e2cenco O, Grumezescu AM, Teleanu DM. Neurotransmitters-key factors in neurological and neurodegenerative disorders of the central nervous system. Int J Mol Sci. 2022;23: 5954. https:\/\/doi.org\/10.3390\/ijms23115954.","journal-title":"Int J Mol Sci"},{"key":"7485_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101558","volume":"74","author":"X Xia","year":"2022","unstructured":"Xia X, Wang Y, Qin Y, Zhao S, Zheng JC. Exosome: a novel neurotransmission modulator or non-canonical neurotransmitter? Ageing Res Rev. 2022;74: 101558. https:\/\/doi.org\/10.1016\/j.arr.2021.101558.","journal-title":"Ageing Res Rev"},{"key":"7485_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26031234","volume":"26","author":"W Yu","year":"2025","unstructured":"Yu W, Zhang R, Zhang A, Mei Y. Deciphering the functions of Raphe-Hippocampal serotonergic and glutamatergic circuits and their deficits in Alzheimer\u2019s disease. Int J Mol Sci. 2025;26: 1234. https:\/\/doi.org\/10.3390\/ijms26031234.","journal-title":"Int J Mol Sci"},{"key":"7485_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106232","volume":"184","author":"T Wu","year":"2023","unstructured":"Wu T, Cai W, Chen X. Epigenetic regulation of neurotransmitter signaling in neurological disorders. Neurobiol Dis. 2023;184: 106232. https:\/\/doi.org\/10.1016\/j.nbd.2023.106232.","journal-title":"Neurobiol Dis"},{"key":"7485_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1124\/pharmrev.122.000618","volume":"75","author":"B Channer","year":"2023","unstructured":"Channer B, Matt SM, Nickoloff-Bybel EA, Pappa V, Agarwal Y, Wickman J, et al. Dopamine, immunity, and disease. Pharmacol Rev. 2023;75:62\u2013158. https:\/\/doi.org\/10.1124\/pharmrev.122.000618.","journal-title":"Pharmacol Rev"},{"key":"7485_CR12","doi-asserted-by":"publisher","first-page":"101556","DOI":"10.1016\/j.arr.2021.101556","volume":"75","author":"E Aaldijk","year":"2022","unstructured":"Aaldijk E, Vermeiren Y. The role of serotonin within the microbiota-gut-brain axis in the development of alzheimer\u2019s disease: A narrative review. Ageing Res Rev. 2022;75:101556. https:\/\/doi.org\/10.1016\/j.arr.2021.101556.","journal-title":"Ageing Res Rev"},{"key":"7485_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41398-024-03073-w","volume":"14","author":"AF Khan","year":"2024","unstructured":"Khan AF, Iturria-Medina Y. Beyond the usual suspects: multi-factorial computational models in the search for neurodegenerative disease mechanisms. Transl Psychiatry. 2024;14:386. https:\/\/doi.org\/10.1038\/s41398-024-03073-w.","journal-title":"Transl Psychiatry"},{"key":"7485_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/hbm.25244","volume":"42","author":"J Dukart","year":"2021","unstructured":"Dukart J, Holiga S, Rullmann M, Lanzenberger R, Hawkins PCT, Mehta MA, et al. Juspace: a tool for spatial correlation analyses of magnetic resonance imaging data with nuclear imaging derived neurotransmitter maps. Hum Brain Mapp. 2021;42:555\u201366. https:\/\/doi.org\/10.1002\/hbm.25244.","journal-title":"Hum Brain Mapp"},{"key":"7485_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106897","volume":"209","author":"RF Morais","year":"2025","unstructured":"Morais RF, Sousa JM, Koba C, Andres L, Jesus T, Baldeiras I, et al. Differential involvement of neurotransmitter pathways in AD, BvFTD and MCI: whole-brain MRI analysis. Neurobiol Dis. 2025;209: 106897. https:\/\/doi.org\/10.1016\/j.nbd.2025.106897.","journal-title":"Neurobiol Dis"},{"key":"7485_CR16","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1503\/jpn.240111","volume":"50","author":"X Liu","year":"2025","unstructured":"Liu X, Chen X, Cheng J, Wei F, Hou H, Li J, et al. Functional connectivity gradients and neurotransmitter maps among patients with mild cognitive impairment and depression symptoms. J Psychiatry Neurosci. 2025;50:E11\u201320. https:\/\/doi.org\/10.1503\/jpn.240111.","journal-title":"J Psychiatry Neurosci"},{"key":"7485_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhae420","author":"H Pang","year":"2024","unstructured":"Pang H, Li X, Yu Z, Yu H, Bu S, Wang J, et al. Disentangling gray matter atrophy and its neurotransmitter architecture in drug-na\u00efve Parkinson\u2019s disease: an atlas-based correlation analysis. Cereb Cortex. 2024. https:\/\/doi.org\/10.1093\/cercor\/bhae420.","journal-title":"Cereb Cortex"},{"key":"7485_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr., Kawas CH, et al. The diagnosis of dementia due to alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s association workgroups on diagnostic guidelines for alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005.","journal-title":"Alzheimers Dement"},{"key":"7485_CR19","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41591-024-02988-7","volume":"30","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews SJ, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for the diagnosis and staging of Alzheimer\u2019s disease. Nat Med. 2024;30:2121\u20134. https:\/\/doi.org\/10.1038\/s41591-024-02988-7.","journal-title":"Nat Med"},{"key":"7485_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183\u201394. https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01388.x.","journal-title":"J Intern Med"},{"key":"7485_CR21","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1212\/WNL.0b013e318292a342","volume":"80","author":"JM Harris","year":"2013","unstructured":"Harris JM, Gall C, Thompson JC, Richardson AM, Neary D, du Plessis D, et al. Sensitivity and specificity of FTDC criteria for behavioral variant frontotemporal dementia. Neurology. 2013;80:1881\u20137. https:\/\/doi.org\/10.1212\/WNL.0b013e318292a342.","journal-title":"Neurology"},{"key":"7485_CR22","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006\u201314. https:\/\/doi.org\/10.1212\/WNL.0b013e31821103e6.","journal-title":"Neurology"},{"key":"7485_CR23","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1007\/s00259-020-04752-8","volume":"47","author":"S Yan","year":"2020","unstructured":"Yan S, Zheng C, Cui B, Qi Z, Zhao Z, An Y, et al. Multiparametric imaging hippocampal neurodegeneration and functional connectivity with simultaneous PET\/MRI in Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2020;47:2440\u201352. https:\/\/doi.org\/10.1007\/s00259-020-04752-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7485_CR24","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1093\/brain\/awab160","volume":"144","author":"S Yan","year":"2021","unstructured":"Yan S, Zheng C, Paranjpe MD, Li Y, Li W, Wang X, et al. Sex modifies APOE epsilon4 dose effect on brain Tau deposition in cognitively impaired individuals. Brain. 2021;144:3201\u201311. https:\/\/doi.org\/10.1093\/brain\/awab160.","journal-title":"Brain"},{"key":"7485_CR25","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/hbm.25774","volume":"43","author":"Y Li","year":"2022","unstructured":"Li Y, Ng YL, Paranjpe MD, Ge Q, Gu F, Li P, et al. Tracer-specific reference tissues selection improves detection of (18) F-FDG, (18) F-florbetapir, and (18) F-flortaucipir PET SUVR changes in Alzheimer\u2019s disease. Hum Brain Mapp. 2022;43:2121\u201333. https:\/\/doi.org\/10.1002\/hbm.25774.","journal-title":"Hum Brain Mapp"},{"key":"7485_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-021-00771-0","volume":"11","author":"A Verger","year":"2021","unstructured":"Verger A, Doyen M, Campion JY, Guedj E. The pons as reference region for intensity normalization in semi-quantitative analysis of brain (18)FDG PET: application to metabolic changes related to ageing in conventional and digital control databases. EJNMMI Res. 2021;11: 31. https:\/\/doi.org\/10.1186\/s13550-021-00771-0.","journal-title":"EJNMMI Res"},{"key":"7485_CR27","doi-asserted-by":"publisher","first-page":"9261","DOI":"10.1038\/s41598-020-65957-3","volume":"10","author":"S Nugent","year":"2020","unstructured":"Nugent S, Croteau E, Potvin O, Castellano CA, Dieumegarde L, Cunnane SC, et al. Selection of the optimal intensity normalization region for FDG-PET studies of normal aging and Alzheimer\u2019s disease. Sci Rep. 2020;10:9261. https:\/\/doi.org\/10.1038\/s41598-020-65957-3.","journal-title":"Sci Rep"},{"key":"7485_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13550-024-01068-8","volume":"14","author":"S Bi","year":"2024","unstructured":"Bi S, Yan S, Chen Z, Cui B, Shan Y, Yang H, et al. Comparison of (18)F-FDG PET and arterial spin labeling MRI in evaluating alzheimer\u2019s disease and amnestic mild cognitive impairment using integrated PET\/MR. EJNMMI Res. 2024;14:9\u201318. https:\/\/doi.org\/10.1186\/s13550-024-01068-8.","journal-title":"EJNMMI Res"},{"key":"7485_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-025-07279-y","author":"H Lin","year":"2025","unstructured":"Lin H, Jiang Q, Yang Y, Huang Q, Zhang Y, Zhang Z, et al. Harmonizing A\u03b2 deposition threshold for (18)F-florbetaben PET imaging: addressing discrepancies and calibration between PET\/CT and PET\/MRI. Eur J Nucl Med Mol Imaging. 2025. https:\/\/doi.org\/10.1007\/s00259-025-07279-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7485_CR30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.neuroimage.2012.07.001","volume":"63","author":"M Savli","year":"2012","unstructured":"Savli M, Bauer A, Mitterhauser M, Ding YS, Hahn A, Kroll T, et al. Normative database of the serotonergic system in healthy subjects using multi-tracer PET. Neuroimage. 2012;63:447\u201359. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.07.001.","journal-title":"Neuroimage"},{"key":"7485_CR31","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00259-017-3645-0","volume":"44","author":"S Kaller","year":"2017","unstructured":"Kaller S, Rullmann M, Patt M, Becker GA, Luthardt J, Girbardt J, et al. Test-retest measurements of dopamine D(1)-type receptors using simultaneous PET\/MRI imaging. Eur J Nucl Med Mol Imaging. 2017;44:1025\u201332. https:\/\/doi.org\/10.1007\/s00259-017-3645-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7485_CR32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/jcbfm.2014.237","volume":"35","author":"CM Sandiego","year":"2015","unstructured":"Sandiego CM, Gallezot JD, Lim K, Ropchan J, Lin SF, Gao H, et al. Reference region modeling approaches for amphetamine challenge studies with [11 C]FLB 457 and PET. J Cereb Blood Flow Metab. 2015;35:623\u20139. https:\/\/doi.org\/10.1038\/jcbfm.2014.237.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7485_CR33","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1038\/s41598-018-22444-0","volume":"8","author":"J Dukart","year":"2018","unstructured":"Dukart J, Holiga \u0160, Chatham C, Hawkins P, Forsyth A, McMillan R, et al. Cerebral blood flow predicts differential neurotransmitter activity. Sci Rep. 2018;8:4074. https:\/\/doi.org\/10.1038\/s41598-018-22444-0.","journal-title":"Sci Rep"},{"key":"7485_CR34","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.remn.2013.02.009","volume":"32","author":"FJ Garc\u00eda-G\u00f3mez","year":"2013","unstructured":"Garc\u00eda-G\u00f3mez FJ, Garc\u00eda-Sol\u00eds D, Luis-Sim\u00f3n FJ, Mar\u00edn-Oyaga VA, Carrillo F, Mir P, et al. Elaboration of the SPM template for the standardization of SPECT images with 123I-Ioflupane. Rev Esp Med Nucl Imagen Mol. 2013;32:350\u20136. https:\/\/doi.org\/10.1016\/j.remn.2013.02.009.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"7485_CR35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/jcbfm.2011.177","volume":"32","author":"JF Myers","year":"2012","unstructured":"Myers JF, Rosso L, Watson BJ, Wilson SJ, Kalk NJ, Clementi N, et al. Characterisation of the contribution of the GABA-benzodiazepine \u03b11 receptor subtype to [(11)C]Ro15-4513 PET images. J Cereb Blood Flow Metab. 2012;32:731\u201344. https:\/\/doi.org\/10.1038\/jcbfm.2011.177.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7485_CR36","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/s41593-022-01186-3","volume":"25","author":"JY Hansen","year":"2022","unstructured":"Hansen JY, Shafiei G, Markello RD, Smart K, Cox SML, N\u00f8rgaard M, et al. Mapping neurotransmitter systems to the structural and functional organization of the human neocortex. Nat Neurosci. 2022;25:1569\u201381. https:\/\/doi.org\/10.1038\/s41593-022-01186-3.","journal-title":"Nat Neurosci"},{"key":"7485_CR37","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41380-018-0130-5","volume":"24","author":"S Nejad-Davarani","year":"2019","unstructured":"Nejad-Davarani S, Koeppe RA, Albin RL, Frey KA, M\u00fcller M, Bohnen NI. Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [(18)F]-FEOBV. Mol Psychiatry. 2019;24:322\u20137. https:\/\/doi.org\/10.1038\/s41380-018-0130-5.","journal-title":"Mol Psychiatry"},{"key":"7485_CR38","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/hbm.25733","volume":"43","author":"E Shokri-Kojori","year":"2022","unstructured":"Shokri-Kojori E, Naganawa M, Ramchandani VA, Wong DF, Wang GJ, Volkow ND. Brain opioid segments and striatal patterns of dopamine release induced by naloxone and morphine. Hum Brain Mapp. 2022;43:1419\u201330. https:\/\/doi.org\/10.1002\/hbm.25733.","journal-title":"Hum Brain Mapp"},{"key":"7485_CR39","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1007\/s00259-016-3590-3","volume":"44","author":"S Hesse","year":"2017","unstructured":"Hesse S, Becker GA, Rullmann M, Bresch A, Luthardt J, Hankir MK, et al. Central noradrenaline transporter availability in highly obese, non-depressed individuals. Eur J Nucl Med Mol Imaging. 2017;44:1056\u201364. https:\/\/doi.org\/10.1007\/s00259-016-3590-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7485_CR40","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/brain\/awx327","volume":"141","author":"AG Murley","year":"2018","unstructured":"Murley AG, Rowe JB. Neurotransmitter deficits from frontotemporal lobar degeneration. Brain. 2018;141:1263\u201385. https:\/\/doi.org\/10.1093\/brain\/awx327.","journal-title":"Brain"},{"key":"7485_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1192\/bjb.2022.100","volume":"48","author":"RH Cole","year":"2024","unstructured":"Cole RH, Clark CN, Poole NA. Semantic dementia: a complex and culturally influenced presentation. BJPsych Bull. 2024;48:44\u201350. https:\/\/doi.org\/10.1192\/bjb.2022.100.","journal-title":"BJPsych Bull"},{"key":"7485_CR42","doi-asserted-by":"publisher","first-page":"e1006733","DOI":"10.1371\/journal.ppat.1006733","volume":"13","author":"D Goniotaki","year":"2017","unstructured":"Goniotaki D, Lakkaraju AKK, Shrivastava AN, Bakirci P, Sorce S, Senatore A, et al. Inhibition of group-I metabotropic glutamate receptors protects against prion toxicity. PLoS Pathog. 2017;13:e1006733. https:\/\/doi.org\/10.1371\/journal.ppat.1006733.","journal-title":"PLoS Pathog"},{"key":"7485_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/jad-190577","volume":"72","author":"SG Snowden","year":"2019","unstructured":"Snowden SG, Ebshiana AA, Hye A, Pletnikova O, O\u2019Brien R, Yang A, et al. Neurotransmitter imbalance in the brain and Alzheimer\u2019s disease pathology. J Alzheimers Dis. 2019;72:35\u201343. https:\/\/doi.org\/10.3233\/jad-190577.","journal-title":"J Alzheimers Dis"},{"key":"7485_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.102146","volume":"25","author":"S Dolui","year":"2020","unstructured":"Dolui S, Li Z, Nasrallah IM, Detre JA, Wolk DA. Arterial spin labeling versus (18)F-FDG-PET to identify mild cognitive impairment. NeuroImage: Clinical. 2020;25: 102146. https:\/\/doi.org\/10.1016\/j.nicl.2019.102146.","journal-title":"NeuroImage: Clinical"},{"key":"7485_CR45","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1007\/s00259-007-0454-x","volume":"34","author":"M Samuraki","year":"2007","unstructured":"Samuraki M, Matsunari I, Chen WP, Yajima K, Yanase D, Fujikawa A, et al. Partial volume effect-corrected FDG PET and grey matter volume loss in patients with mild Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2007;34:1658\u201369. https:\/\/doi.org\/10.1007\/s00259-007-0454-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7485_CR46","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1148\/radiol.12120928","volume":"267","author":"MA Binnewijzend","year":"2013","unstructured":"Binnewijzend MA, Kuijer JP, Benedictus MR, van der Flier WM, Wink AM, Wattjes MP, et al. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology. 2013;267:221\u201330.","journal-title":"Radiology"},{"key":"7485_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.tics.2018.12.006","volume":"23","author":"T Ott","year":"2019","unstructured":"Ott T, Nieder A. Dopamine and cognitive control in prefrontal cortex. Trends Cogn Sci. 2019;23:213\u201334. https:\/\/doi.org\/10.1016\/j.tics.2018.12.006.","journal-title":"Trends Cogn Sci"},{"key":"7485_CR48","doi-asserted-by":"publisher","first-page":"543","DOI":"10.4103\/1673-5374.320970","volume":"17","author":"Y Ju","year":"2022","unstructured":"Ju Y, Tam KY. Pathological mechanisms and therapeutic strategies for Alzheimer\u2019s disease. Neural Regen Res. 2022;17:543\u20139. https:\/\/doi.org\/10.4103\/1673-5374.320970.","journal-title":"Neural Regen Res"},{"key":"7485_CR49","doi-asserted-by":"publisher","first-page":"108602","DOI":"10.1016\/j.neuropharm.2021.108602","volume":"192","author":"AG Rodr\u00edguez-Campuzano","year":"2021","unstructured":"Rodr\u00edguez-Campuzano AG, Ortega A. Glutamate transporters: critical components of glutamatergic transmission. Neuropharmacology. 2021;192:108602. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108602.","journal-title":"Neuropharmacology"},{"key":"7485_CR50","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1177\/1073858417734530","volume":"24","author":"T Schmidt-Wilcke","year":"2018","unstructured":"Schmidt-Wilcke T, Fuchs E, Funke K, Vlachos A, M\u00fcller-Dahlhaus F, Puts NAJ, et al. GABA-from inhibition to cognition: emerging concepts. Neuroscientist. 2018;24:501\u201315. https:\/\/doi.org\/10.1177\/1073858417734530.","journal-title":"Neuroscientist"},{"key":"7485_CR51","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1093\/brain\/awab111","volume":"144","author":"N Holland","year":"2021","unstructured":"Holland N, Robbins TW, Rowe JB. The role of noradrenaline in cognition and cognitive disorders. Brain. 2021;144:2243\u201356. https:\/\/doi.org\/10.1093\/brain\/awab111.","journal-title":"Brain"},{"key":"7485_CR52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrn1588","volume":"6","author":"M Sarter","year":"2005","unstructured":"Sarter M, Parikh V. Choline transporters, cholinergic transmission and cognition. Nat Rev Neurosci. 2005;6:48\u201356. https:\/\/doi.org\/10.1038\/nrn1588.","journal-title":"Nat Rev Neurosci"},{"key":"7485_CR53","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.86085","author":"L Hahn","year":"2024","unstructured":"Hahn L, Eickhoff SB, Mueller K, Schilbach L, Barthel H, Fassbender K, et al. Resting-state alterations in behavioral variant frontotemporal dementia are related to the distribution of monoamine and GABA neurotransmitter systems. Elife. 2024. https:\/\/doi.org\/10.7554\/eLife.86085.","journal-title":"Elife"},{"key":"7485_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106068","volume":"179","author":"E Premi","year":"2023","unstructured":"Premi E, Pengo M, Mattioli I, Cantoni V, Dukart J, Gasparotti R, et al. Early neurotransmitters changes in prodromal frontotemporal dementia: a GENFI study. Neurobiol Dis. 2023;179: 106068. https:\/\/doi.org\/10.1016\/j.nbd.2023.106068.","journal-title":"Neurobiol Dis"},{"key":"7485_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01466-z","volume":"16","author":"J Lagarde","year":"2024","unstructured":"Lagarde J, Olivieri P, Tonietto M, Noiray C, Lehericy S, Valabr\u00e8gue R, et al. Combined in vivo MRI assessment of locus coeruleus and nucleus basalis of meynert integrity in amnestic Alzheimer\u2019s disease, suspected-LATE and frontotemporal dementia. Alzheimers Res Ther. 2024;16: 97. https:\/\/doi.org\/10.1186\/s13195-024-01466-z.","journal-title":"Alzheimers Res Ther"},{"key":"7485_CR56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12017-012-8180-3","volume":"14","author":"Z Cai","year":"2012","unstructured":"Cai Z, Ratka A. Opioid system and Alzheimer\u2019s disease. Neuromolecular Med. 2012;14:91\u2013111. https:\/\/doi.org\/10.1007\/s12017-012-8180-3.","journal-title":"Neuromolecular Med"},{"key":"7485_CR57","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13195-021-00788-6","volume":"13","author":"A Nous","year":"2021","unstructured":"Nous A, Engelborghs S, Smolders I. Melatonin levels in the Alzheimer\u2019s disease continuum: a systematic review. Alzheimers Res Ther. 2021;13:52. https:\/\/doi.org\/10.1186\/s13195-021-00788-6.","journal-title":"Alzheimers Res Ther"},{"key":"7485_CR58","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.semcdb.2021.01.005","volume":"116","author":"J Jim\u00e9nez-Balado","year":"2021","unstructured":"Jim\u00e9nez-Balado J, Eich TS. GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer\u2019s disease. Semin Cell Dev Biol. 2021;116:146\u201359. https:\/\/doi.org\/10.1016\/j.semcdb.2021.01.005.","journal-title":"Semin Cell Dev Biol"},{"key":"7485_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13286","volume":"20","author":"J Lu","year":"2021","unstructured":"Lu J, Zhang C, Lv J, Zhu X, Jiang X, Lu W, et al. Antiallergic drug desloratadine as a selective antagonist of 5HT(2A) receptor ameliorates pathology of Alzheimer\u2019s disease model mice by improving microglial dysfunction. Aging Cell. 2021;20: e13286. https:\/\/doi.org\/10.1111\/acel.13286.","journal-title":"Aging Cell"},{"key":"7485_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00859-8","volume":"13","author":"Y Li","year":"2021","unstructured":"Li Y, Zhu K, Li N, Wang X, Xiao X, Li L, et al. Reversible GABAergic dysfunction involved in hippocampal hyperactivity predicts early-stage Alzheimer disease in a mouse model. Alzheimers Res Ther. 2021;13: 114. https:\/\/doi.org\/10.1186\/s13195-021-00859-8.","journal-title":"Alzheimers Res Ther"},{"key":"7485_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112787","volume":"206","author":"S Manzoor","year":"2020","unstructured":"Manzoor S, Hoda N. A comprehensive review of monoamine oxidase inhibitors as anti-Alzheimer\u2019s disease agents: a review. Eur J Med Chem. 2020;206: 112787. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112787.","journal-title":"Eur J Med Chem"},{"key":"7485_CR62","doi-asserted-by":"publisher","first-page":"eadk1822","DOI":"10.1126\/scisignal.adk1822","volume":"17","author":"N Watamura","year":"2024","unstructured":"Watamura N, Kakiya N, Fujioka R, Kamano N, Takahashi M, Nilsson P, et al. The dopaminergic system promotes neprilysin-mediated degradation of amyloid-\u03b2 in the brain. Sci Signal. 2024;17:eadk1822. https:\/\/doi.org\/10.1126\/scisignal.adk1822.","journal-title":"Sci Signal"},{"key":"7485_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-017-0298-y","volume":"9","author":"CU von Linstow","year":"2017","unstructured":"von Linstow CU, Waider J, Grebing M, Metaxas A, Lesch KP, Finsen B. Serotonin augmentation therapy by Escitalopram has minimal effects on amyloid-\u03b2 levels in early-stage Alzheimer\u2019s-like disease in mice. Alzheimers Res Ther. 2017;9: 74. https:\/\/doi.org\/10.1186\/s13195-017-0298-y.","journal-title":"Alzheimers Res Ther"},{"key":"7485_CR64","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/s41586-024-07638-z","volume":"632","author":"T Hu","year":"2024","unstructured":"Hu T, Yu Z, Zhao J, Meng Y, Salomon K, Bai Q, et al. Transport and inhibition mechanisms of the human noradrenaline transporter. Nature. 2024;632:930\u20137. https:\/\/doi.org\/10.1038\/s41586-024-07638-z.","journal-title":"Nature"},{"key":"7485_CR65","doi-asserted-by":"publisher","first-page":"eaay6931","DOI":"10.1126\/scitranslmed.aay6931","volume":"12","author":"F Zhang","year":"2020","unstructured":"Zhang F, Gannon M, Chen Y, Yan S, Zhang S, Feng W, et al. \u03b2-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3\u03b2\/tau cascade. Sci Transl Med. 2020;12:eaay6931. https:\/\/doi.org\/10.1126\/scitranslmed.aay6931.","journal-title":"Sci Transl Med"},{"key":"7485_CR66","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41398-020-0841-7","volume":"10","author":"LE Pillet","year":"2020","unstructured":"Pillet LE, Taccola C, Cotoni J, Thiriez H, Andr\u00e9 K, Verpillot R. Correlation between cognition and plasma noradrenaline level in Alzheimer\u2019s disease: a potential new blood marker of disease evolution. Transl Psychiatry. 2020;10:213. https:\/\/doi.org\/10.1038\/s41398-020-0841-7.","journal-title":"Transl Psychiatry"},{"key":"7485_CR67","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712\u20136. https:\/\/doi.org\/10.1126\/science.aad8373.","journal-title":"Science"},{"key":"7485_CR68","doi-asserted-by":"publisher","first-page":"101397","DOI":"10.1016\/j.arr.2021.101397","volume":"70","author":"A Wi\u0119ckowska-Gacek","year":"2021","unstructured":"Wi\u0119ckowska-Gacek A, Mietelska-Porowska A, Wydrych M, Wojda U. Western diet as a trigger of alzheimer\u2019s disease: from metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration. Ageing Res Rev. 2021;70:101397. https:\/\/doi.org\/10.1016\/j.arr.2021.101397.","journal-title":"Ageing Res Rev"},{"key":"7485_CR69","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-024-00432-x","volume":"13","author":"E Liu","year":"2024","unstructured":"Liu E, Zhang Y, Wang JZ. Updates in Alzheimer\u2019s disease: from basic research to diagnosis and therapies. Transl Neurodegener. 2024;13:45. https:\/\/doi.org\/10.1186\/s40035-024-00432-x.","journal-title":"Transl Neurodegener"},{"key":"7485_CR70","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/jnc.15260","volume":"156","author":"CM Yuede","year":"2021","unstructured":"Yuede CM, Wallace CE, Davis TA, Gardiner WD, Hettinger JC, Edwards HM, et al. Pimavanserin, a 5HT(2A) receptor inverse agonist, rapidly suppresses A\u03b2 production and related pathology in a mouse model of Alzheimer\u2019s disease. J Neurochem. 2021;156:658\u201373. https:\/\/doi.org\/10.1111\/jnc.15260.","journal-title":"J Neurochem"},{"key":"7485_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/cells8060550","author":"BL Tang","year":"2019","unstructured":"Tang BL. Amyloid precursor protein (APP) and GABAergic neurotransmission. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8060550.","journal-title":"Cells"},{"key":"7485_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0491-2","volume":"11","author":"A Metaxas","year":"2019","unstructured":"Metaxas A, Anzalone M, Vaitheeswaran R, Petersen S, Landau AM, Finsen B. Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer\u2019s disease. Alzheimers Res Ther. 2019;11: 38. https:\/\/doi.org\/10.1186\/s13195-019-0491-2.","journal-title":"Alzheimers Res Ther"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07485-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07485-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07485-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:46:21Z","timestamp":1769222781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07485-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7485"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07485-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was\u00a0granted by the Ethics Committee of Capital Medical University (No. [2023]044]).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}